MedTrace Logo

Treatment of Postpartum Haemorrhage (PPH) Using Misoprostol in Home Births

NCT01485562 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2016-03-10

No results posted yet for this study

Summary

A double-blind individual randomized controlled study of misoprostol vs. placebo for treatment in homebirths in the Chitral district, in the Khyber Pakhtunkhwa province in Pakistan.

Conditions

  • Postpartum Haemorrhage

Interventions

DRUG

Misoprostol

4 tablets of 200 mcg misoprostol administered sublingually if the woman experiences a PPH after child birth

OTHER

placebo

4 tablets, administered sublingually if the woman experiences a PPH

Sponsors & Collaborators

  • Aga Khan Health Services

    collaborator OTHER

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Zafar Khan · Aga Khan Health Services

  • Nadeem Zuberi · Aga Khan University

  • Gijs Walraven · Secretariat of His Highness the Aga Khan, Aiglemont

  • Ayisha Diop · Gynuity Health Projects

  • Dina Abbas · Gynuity Health Projects

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01485562 on ClinicalTrials.gov